Early mortality among adults accessing antiretroviral treatment programmes in sub-Saharan Africa.
about
Dose adjustment of the non-nucleoside reverse transcriptase inhibitors during concurrent rifampicin-containing tuberculosis therapy: one size does not fit allPaucity of initial cerebrospinal fluid inflammation in cryptococcal meningitis is associated with subsequent immune reconstitution inflammatory syndromeRole of Education in HIV Clinical Outcomes in a Tuberculosis Endemic SettingScreening for Tuberculosis Among Adults Newly Diagnosed With HIV in Sub-Saharan Africa: A Cost-Effectiveness AnalysisHIV and tuberculosis--science and implementation to turn the tide and reduce deathsHarnessing the prevention benefits of antiretroviral therapy to address HIV and tuberculosisExtensive Central Nervous System Cryptococcal Disease Presenting as Immune Reconstitution Syndrome in a Patient with Advanced HIV: Report of a Case and Review of Management Dilemmas and StrategiesPreventing Cryptococcosis-Shifting the Paradigm in the Era of Highly Active Antiretroviral TherapyRising to the challenge: new therapies for tuberculosisThe effect of tuberculosis treatment at combination antiretroviral therapy initiation on subsequent mortality: a systematic review and meta-analysisData needs for evidence-based decisions: a tuberculosis modeler's 'wish list'HIV-Associated Cryptococcal Meningitis: Bridging the Gap Between Developed and Resource-Limited SettingsEffectiveness of isoniazid preventative therapy in reducing incidence of active tuberculosis among people living with HIV/AIDS in public health facilities of Addis Ababa, Ethiopia: a historical cohort studyPredictors of tuberculosis in first 6 months after initiation of antiretroviral therapy: a case-control studyMortality of HIV-infected patients starting antiretroviral therapy in sub-Saharan Africa: comparison with HIV-unrelated mortalityScaling up the 2010 World Health Organization HIV Treatment Guidelines in resource-limited settings: a model-based analysisScreening for HIV-associated tuberculosis and rifampicin resistance before antiretroviral therapy using the Xpert MTB/RIF assay: a prospective studyComplications of antiretroviral therapy initiation in hospitalised patients with HIV-associated tuberculosisCost effectiveness of cryptococcal antigen screening as a strategy to prevent HIV-associated cryptococcal meningitis in South AfricaOutcomes in a Cohort of Patients Started on Antiretroviral Treatment and Followed up for a Decade in an Urban Clinic in UgandaPredictors of Treatment Failure among Adult Antiretroviral Treatment (ART) Clients in Bale Zone Hospitals, South Eastern EthiopiaHIV care in Yangon, Myanmar; successes, challenges and implications for policy.A novel experimental model of Cryptococcus neoformans-related immune reconstitution inflammatory syndrome (IRIS) provides insights into pathogenesis.Timing of antiretroviral therapy and TB treatment outcomes in patients with TB-HIV in MyanmarHealth services utilization among South African women living with HIV and reporting sexual and substance-use risk behaviors.HIV infection and tuberculosis in South Africa: an urgent need to escalate the public health response.High early mortality in patients with chronic acquired immunodeficiency syndrome diarrhea initiating antiretroviral therapy in Haiti: a case-control studyMortality and loss-to-follow-up during the pre-treatment period in an antiretroviral therapy programme under normal health service conditions in Uganda.Perceptions of tuberculosis patients on provider-initiated HIV testing and counseling--a study from south IndiaImplementation and Operational Research: Risk Charts to Guide Targeted HIV-1 Viral Load Monitoring of ART: Development and Validation in Patients From Resource-Limited Settings.Missed opportunities for retention in pre-ART care in Cape Town, South AfricaIncident tuberculosis during antiretroviral therapy contributes to suboptimal immune reconstitution in a large urban HIV clinic in sub-Saharan AfricaVirological success after 12 and 24 months of antiretroviral therapy in sub-Saharan Africa: Comparing results of trials, cohorts and cross-sectional studies using a systematic review and meta-analysis.Serum phosphate predicts early mortality in adults starting antiretroviral therapy in Lusaka, Zambia: a prospective cohort studyRates of virological failure in patients treated in a home-based versus a facility-based HIV-care model in Jinja, southeast Uganda: a cluster-randomised equivalence trialPredictors of Survival among Adult Ethiopian Patients in the National ART Program at Seven University Teaching Hospitals: A Prospective Cohort StudyEmpirical treatment for TB in HIV: lessons from a cohort study of people living with HIV treated in Recife, Brazil.Linkage to HIV care and antiretroviral therapy by HIV testing service type in Central Mozambique: a retrospective cohort study.Disparities in HIV Clinical Outcomes among a Cohort of HIV-Infected Persons Receiving Care-Mississippi.Short and Long-Term Incidence of Tuberculosis and CD4-Cell Count Dynamic on HAART in Senegal
P2860
Q24609011-FFF64AFC-A81C-423F-8852-A57DC10B4556Q24630287-827755F2-8512-4D49-946B-A4E2C34BE1AAQ25017374-DF69117A-363A-498C-940C-F34F6A01829EQ26779464-BB81F0E0-CBCE-49F6-B551-03DA27403259Q26824501-92088B97-93B7-4D68-A5D5-882D8008A81EQ26828443-0C0A6DD4-ADB7-4E16-B716-95B0BDD6B550Q26852378-64F2384F-D606-4B32-B29C-4DA4FFA05E29Q26994750-47F51904-AE02-49FE-893C-C5C2180CB69CQ27011672-7B967190-7769-48A6-90BE-5D1B907ACFB5Q27014121-EF365553-10BA-4D98-980F-4E0BDBB95CA1Q27015848-FB651A39-40F0-4D51-944A-BC544E114BC7Q28078958-08F91DA0-4934-45D5-AA25-40C9AA44159FQ28359604-5D59C75F-CA35-4D3B-AA81-13E8F698F85BQ28397102-9DA99A81-E412-4699-B0AF-9266441CE9ACQ28475331-CA2738B9-0123-427D-9613-3D246D1227F6Q28476684-D01F4E46-7E33-49EA-AA7F-B60444C8965AQ28479309-7884006C-0CD4-44DE-B6A9-0F168D383BC3Q28486096-415673E4-2FB4-4EAA-ADF7-527D1BE4BA49Q28534733-EB347D7F-A8B1-4196-B3DE-6BC30B6F4CFEQ28551380-07E436B1-C308-44C8-9D4E-C500C57F0331Q28554591-80947F6C-CEF6-4CB1-814E-CBE5D1C61A73Q30378383-7389CCDA-FDF1-44F0-AB9A-5805E5F111F4Q30379272-06BFD5F2-B0CD-49F1-9B18-237BE3C0E361Q30383131-3DEBD2BE-EB87-47C5-A4D3-EFDF97FFA41DQ30387883-4542B065-6A3F-44CD-9A71-9439D2CBB26BQ30397119-E43FC69A-D0AB-46B6-B88A-ACA07A2CBC69Q30414385-16B0DCBC-DA57-405A-8B00-7BBC1D9C19DCQ33492607-566C990E-B47F-4F09-BC65-956591D094D0Q33521250-8F40280D-3BC4-4EA0-B829-C3C80AA945BEQ33576031-F781A03C-F448-476B-B4D6-7116D901B2C2Q33578341-D92FBCB2-A7F2-4C0F-965C-5AA279BFCB05Q33580153-6DA4856B-82AA-4E65-8CAC-F0C52A60B8E1Q33584656-223AE3D3-0EF7-465B-AAD1-A04583C07F65Q33587556-918FAFF6-BC4A-4E94-8000-8B5BA1E3E19CQ33590533-8287217C-BAD8-43A0-BD2F-8A4E9C05B881Q33596118-4730716A-188F-4793-BA97-434B92E912AFQ33609334-EB21C38E-21D9-4D86-AE8F-22A7CC1B81B5Q33610797-8BE0F32F-7911-47A8-97F8-C6EFA599EB7BQ33616163-44ED79EA-4955-46C6-B8FC-6F60667E2C65Q33616426-C93F3B16-87B2-4110-BDEC-CDE4E7C33334
P2860
Early mortality among adults accessing antiretroviral treatment programmes in sub-Saharan Africa.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on October 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Early mortality among adults a ...... grammes in sub-Saharan Africa.
@en
Early mortality among adults a ...... grammes in sub-Saharan Africa.
@nl
type
label
Early mortality among adults a ...... grammes in sub-Saharan Africa.
@en
Early mortality among adults a ...... grammes in sub-Saharan Africa.
@nl
prefLabel
Early mortality among adults a ...... grammes in sub-Saharan Africa.
@en
Early mortality among adults a ...... grammes in sub-Saharan Africa.
@nl
P2860
P31
P50
P1433
P1476
Early mortality among adults a ...... grammes in sub-Saharan Africa.
@en
P2093
Anthony D Harries
P2860
P304
P356
10.1097/QAD.0B013E32830007CD
P407
P577
2008-10-01T00:00:00Z